Production of hydroxycinnamoyl anthranilates from glucose in Escherichia coli

Microbial Cell Factories

Volumn 12, Issue 1, 2013, Pages

  Eudes, Aymerick ^a,b   Juminaga, Darmawi ^a,c   Baidoo, Edward E K ^a   Collins, F William ^d   Keasling, Jay D ^a,b,c,e   Loqué, Dominique ^a,b  

^a JOINT BIOENERGY INSTITUTE   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c Berkeley   (United States)

^d OTTAWA RESEARCH AND DEVELOPMENT CENTRE   (Canada)

^e University of California   (United States)

Author keywords

Anthranilate; Anti inflammatory; Antioxidant; Avenanthramide; BAHD; Biological synthesis; Escherichia coli; Hydroxycinnamate; Tranilast; Tyrosine

Indexed keywords

AMMONIA LYASE; ANTHRANILIC ACID DERIVATIVE; COENZYME A; GLUCOSE; TYROSINE;

ARABIDOPSIS THALIANA; ARTICLE; BIOSYNTHESIS; CARNATION; ESCHERICHIA COLI; GENE EXPRESSION; NONHUMAN; NUCLEOTIDE SEQUENCE; RHODOTORULA GLUTINIS; SACCHAROMYCES CEREVISIAE; SYNTHESIS; TOBACCO;

ACYLTRANSFERASES; AMMONIA-LYASES; ARABIDOPSIS; BIOSYNTHETIC PATHWAYS; CAFFEIC ACIDS; COENZYME A LIGASES; DIANTHUS; ESCHERICHIA COLI; FUNGAL PROTEINS; GENETIC ENGINEERING; GLUCOSE; MIXED FUNCTION OXYGENASES; ORTHO-AMINOBENZOATES; PLANT PROTEINS; PLASMIDS; RHODOTORULA; TYROSINE;

ARABIDOPSIS THALIANA; AVENA; DIANTHUS; ESCHERICHIA; ESCHERICHIA COLI; NICOTIANA TABACUM; RHODOTORULA GLUTINIS; SACCHAROMYCES CEREVISIAE; SACCHAROTHRIX ESPANAENSIS;

EID: 84879452045     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-12-62     Document Type: Article

References (63)

1. Collins FW. Oat phenolics: avenanthramides, novel substituted N-cinnamoylanthranilate alkaloids from oat groats and hulls. J Agric Food Chem 1989, 37:60-66.
2. Collins FW, Mullin WJ. High-performance liquid chromatographic determination of avenanthramides, N-aroylanthranilic acid alkaloids from oats. J Chromatogr 1988, 45:363-370.
3. Peterson DM, Burrup DE, Wesenberg DM, Erickson CA. Relationships among agronomic traits and grain composition in Oat genotypes grown in different environments. Crop Sci 2005, 45:1249-1255.
4. Singh R, De S, Belkheir A. Avena sativa (Oat), a potential neutraceutical and therapeutic agent: an overview. Crit Rev Food SciNut 2013, 53:126-144.
5. Meydani M. Potential health benefits of avenanthramides of oats. Nutr Rev 2009, 67:731-735. 10.1111/j.1753-4887.2009.00256.x, 19941618.
6. Guo W, Kong E, Meydani M. Dietary polyphenols, inflammation, and cancer. Nutr Cancer 2009, 61:807-810. 10.1080/01635580903285098, 20155620.
7. Ji LL, Lay D, Chung E, Fu Y, Peterson DM. Effect of avenathramides on oxidant generation and antioxidant enzyme activity in exercised rats. Nutr Res 2003, 23:1579-1590.
8. O'Moore KM, Vanlandschoot CM, Dickman JR, Figi AR, Rothert AM, Ji LL. Effect of avenanthramides on rat skeletal muscle injury induced by lengthening contraction. Med Sci Sports Exer 2005, 37(Suppl 5):466.
9. Ren Y, Yang X, Niu X, Liu S, Ren G. Chemical characterization of the avenanthramide-rich extract from oat and its effect on D-galactose-induced oxidative stress in mice. J Agric Food Chem 2011, 59:206-211. 10.1021/jf103938e, 21141964.
10. Liu L, Zubik L, Collins FW, Marko M, Meydani M. The antiatherogenic potential of oat phenolic compounds. Atherosclerosis 2004, 175:39-49. 10.1016/j.atherosclerosis.2004.01.044, 15186945.
11. Guo W, Wise ML, Collins FW, Meydani M. Avenanthramides, polyphenols from oats, inhibit IL-1beta-induced NF-kappaB activation in endothelial cells. Free RadicBiol Med 2008, 44:415-429.
12. Lv N, Song MY, Lee YR, Choi HN, Kwon KB, Park JW, Park BH. Dihydroavenanthramide D protects pancreatic beta-cells from cytokine and streptozotocin toxicity. Biochem Biophys Res Commun 2009, 387:97-102. 10.1016/j.bbrc.2009.06.133, 19576175.
13. Lee YR, Noh EM, Oh HJ, Hur H, Kim JM, Han JH, Hwang JK, Park BH, Park JW, Youn HJ, Jung SH, Kim BS, Jung JY, Lee SH, Park CS, Kim JS. Dihydroavenanthramide D inhibits human breast cancer cell invasion through suppression of MMP-9 expression. Biochem Biophys Res Commun 2011, 405:552-557. 10.1016/j.bbrc.2011.01.065, 21262201.
14. Sur R, Nigam A, Grote D, Liebel F, Southall MD. Avenanthramides, polyphenols from oats, exhibit anti-inflammatory and anti-itch activity. Arch Dermatol Res 2008, 300:569-574. 10.1007/s00403-008-0858-x, 18461339.
15. Heuschkel S, Wohlrab J, Schmaus G, Neubert RH. Modulation of dihydroavenanthramide D release and skin penetration by 1,2-alkanediols. Eur J Pharm Biopharm 2008, 70:239-247. 10.1016/j.ejpb.2008.04.005, 18514497.
16. Nie L, Wise ML, Peterson DM, Meydani M. Avenanthramide, a polyphenol from oats, inhibits vascular smooth muscle cell proliferation and enhances nitric oxide production. Atherosclerosis 2006, 186:260-266. 10.1016/j.atherosclerosis.2005.07.027, 16139284.
17. Nie L, Wise M, Peterson D, Meydani M. Mechanism by which avenanthramide-c, a polyphenol of oats, blocks cell cycle progression in vascular smooth muscle cells. Free Radic Biol Med 2006, 41:702-708. 10.1016/j.freeradbiomed.2006.04.020, 16895790.
18. Guo W, Nie L, Wu D, Wise ML, Collins FW, Meydani SN, Meydani M. Avenanthramides inhibit proliferation of human colon cancer cell lines in vitro. Nutr Cancer 2010, 62:1007-1016. 10.1080/01635581.2010.492090, 21058188.
19. Azuma H, Banno K, Yoshimura T. Pharmacological properties of N-(3′,4′-dimethoxycinnamoyl) anthranilic acid (N-5′), a new anti-atopic agent. Br J Pharmacol 1976, 58:483-488. 10.1111/j.1476-5381.1976.tb08614.x, 1667496, 63304.
20. Isaji M, Miyata H, Ajisawa Y. Tranilast: a new application in the cardiovascular field as an antiproliferative drug. Cardiovasc Drug Rev 1998, 16:288-299.
21. Suzawa H, Kikuchi S, Ichikawa K, Koda A. Inhibitory action of Tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages. Jpn J Pharmacol 1992, 60:85-90. 10.1254/jjp.60.85, 1282575.
22. Crittenden DB, Pillinger MH. The year in gout - 2010-2011. Bull NYU Hosp Jt Dis 2011, 69:257-263.
23. Inglis JJ, Criado G, Andrews M, Feldmann M, Williams RO, Selley ML. The anti-allergic drug, N-(3′,4′-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis. Rheumatology 2007, 46:1428-1432. 10.1093/rheumatology/kem160, 17644821.
24. Platten M, Ho PP, Youssef S, Fontoura P, Garren H, Hur EM, Gupta R, Lee LY, Kidd BA, Robinson WH, Sobel RA, Selley ML, Steinman L. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 2005, 310:850-855. 10.1126/science.1117634, 16272121.
25. Rogosnitzky M, Danks R, Kardash E. Therapeutic Potential of Tranilast, an Anti-allergy Drug, in Proliferative Disorders. Anticancer Res 2012, 32:2471-2478.
26. Zammit SC, Cox AJ, Gow RM, Zhang Y, Gilbert RE, Krum H, Kelly DJ, Williams SJ. Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates. Bioorg Med Chem Lett 2009, 19:7003-7006. 10.1016/j.bmcl.2009.09.120, 19879136.
27. Zhang Y, Edgley AJ, Cox AJ, Powell AK, Wang B, Kompa AR, Stapleton DI, Zammit SC, Williams SJ, Krum H, Gilbert RE, Kelly DJ. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy. Eur J Heart Fail 2012, 14:549-562. 10.1093/eurjhf/hfs011, 22417655.
28. Zhang Y, Elsik M, Edgley AJ, Cox AJ, Kompa AR, Wang B, Tan CY, Khong FL, Stapleton DI, Zammit S, Williams SJ, Gilbert RE, Krum H, Kelly DJ. A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction. Int J Cardio 2012, PMID:23219315.
29. Tan SM, Zhang Y, Wang B, Tan CY, Zammit SC, Williams SJ, Krum H, Kelly DJ. An orally active anti-fibrotic compound, FT23, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy. Clin Exp Pharmacol Physiol 2012, 39:650-656. 10.1111/j.1440-1681.2012.05726.x, 22612418.
30. Gilbert RE, Zhang Y, Williams SJ, Zammit SC, Stapleton DI, Cox AJ, Krum H, Langham R, Kelly DJ. A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat. PLoS One 2012, 7:e47160. 10.1371/journal.pone.0047160, 3468513, 23071743.
31. Keasling JD. Manufacturing molecules through metabolic engineering. Science 2010, 330:1355-1358. 10.1126/science.1193990, 21127247.
32. Pickens LB, Tang Y, Chooi YH. Metabolic engineering for the production of natural products. Annu Rev Chem Biomol Eng 2011, 2:211-236. 10.1146/annurev-chembioeng-061010-114209, 22432617.
33. Williams SJ, Stapleton D, Zammit S, James D, Ernest R, Krum H. Therapeutic compounds 2010, United States: Patent Application No. 2010/0130497 A1.
34. Fielder DA, Redmond MJ, Cottrell IW. Avenanthramide-containing compositions 2010, United States: Patent Application No. 2010/0267662 A1.
35. Yang Q, Reinhard K, Schiltz E, Matern U. Characterization and heterologous expression of hydroxycinnamoyl/benzoyl-CoA:anthranilate N-hydroxycinnamoyl/benzoyltransferase from elicited cell cultures of carnation Dianthus caryophyllus L. Plant Mol Biol 1997, 35:777-789. 10.1023/A:1005878622437, 9426598.
36. D'Auria J. Acyltransferases in plants: a good time to be BAHD. Curr Opin Plant Biol 2006, 9:331-340. 10.1016/j.pbi.2006.03.016, 16616872.
37. Hamberger B, Hahlbrock K. The 4-coumarate:CoA ligase gene family in Arabidopsis thaliana comprises one rare, sinapate-activating and three commonly occurring isoenzymes. Proc Natl Acad Sci USA 2004, 101:2209-2214. 10.1073/pnas.0307307101, 357076, 14769935.
38. Eudes A, Baidoo EE, Yang F, Burd H, Hadi MZ, Collins FW, Keasling JD, Loqué D. Production of tranilast [N-(3′,4′-dimethoxycinnamoyl)-anthranilic acid] and its analogs in yeast Saccharomyces cerevisiae. Appl Microbiol Biotechnol 2011, 89:989-1000. 10.1007/s00253-010-2939-y, 20972784.
39. Ajikumar PK, Tyo K, Carlsen S, Mucha O, Phon TH, Stephanopoulos G. Terpenoids: opportunities for biosynthesis of natural product drugs using engineered microorganisms. Mol Pharm 2008, 5:167-190. 10.1021/mp700151b, 18355030.
40. Gosset G. Production of aromatic compounds in bacteria. Curr Opin Biotechnol 2009, 20:651-658. 10.1016/j.copbio.2009.09.012, 19875279.
41. Balderas-Hernández VE, Sabido-Ramos A, Silva P, Cabrera-Valladares N, Hernández-Chávez G, Báez-Viveros JL, Martínez A, Bolívar F, Gosset G. Metabolic engineering for improving anthranilate synthesis from glucose in Escherichia coli. Microb Cell Fact 2009, 8:19. 10.1186/1475-2859-8-19, 2671490, 19341482.
42. Yanofsky C, Horn V, Bonner M, Stasiowski S. Polarity and enzyme functions in mutants of the first three genes of the tryptophan operon of Escherichia col. Genetics 1971, 69:409-433. 1224543, 4945859.
43. Vannelli T, Wei Qi W, Sweigard J, Gatenby AA, Sariaslani FS. Production of p-hydroxycinnamic acid from glucose in Saccharomyces cerevisiae and Escherichia coli by expression of heterologous genes from plants and fungi. Metab Eng 2007, 9:142-151. 10.1016/j.ymben.2006.11.001, 17204442.
44. Qi WW, Vannelli T, Breinig S, Ben-Bassat A, Gatenby AA, Haynie SL, Sariaslani FS. Functional expression of prokaryotic and eukaryotic genes in Escherichia coli for conversion of glucose to p-hydroxystyrene. Metab Eng 2007, 9:268-276. 10.1016/j.ymben.2007.01.002, 17451990.
45. Juminaga D, Baidoo EE, Redding-Johanson AM, Batth TS, Burd H, Mukhopadhyay A, Petzold CJ, Keasling JD. Modular engineering of L-tyrosine production in Escherichia coli. Appl Environ Microbiol 2012, 78:89-98. 10.1128/AEM.06017-11, 3255607, 22020510.
46. Lin Y, Yan Y. Biosynthesis of caffeic acid in Escherichia coli using its endogenous hydroxylase complex. Microb Cell Fact 2012, 11:42. 10.1186/1475-2859-11-42, 3379962, 22475509.
47. Berner M, Krug D, Bihlmaier C, Vente A, Müller R, Bechthold A. Genes and enzymes involved in caffeic acid biosynthesis in the actinomyceteSaccharothrix espanaensis. J Bacteriol 2006, 188:2666-2673. 10.1128/JB.188.7.2666-2673.2006, 1428420, 16547054.
48. Rautengarten C, Baidoo E, Keasling JD, Scheller HV. A simple method for enzymatic synthesis of unlabeled and radiolabeled hydroxycinnamate-CoA. Bioenerg Res 2010, 3:115-122.
49. Kang SY, Choi O, Lee JK, Hwang BY, Uhm TB, Hong YS. Artificial biosynthesis of phenylpropanoic acids in a tyrosine overproducing Escherichia coli strain. Microb Cell Fact 2012, 11:153. 10.1186/1475-2859-11-153, 3554431, 23206756.
50. Zhang H, Stephanopoulos G. Engineering E. coli for caffeic acid biosynthesis from renewable sugars. Appl Microbiol Biotechnol 2012, 97:3333.
51. Choi O, Wu CZ, Kang SY, Ahn JS, Uhm TB, Hong YS. Biosynthesis of plant-specific phenylpropanoids by construction of an artificial biosynthetic pathway in Escherichia coli. J Ind Microbiol Biotechnol 2011, 38:1657-1665. 10.1007/s10295-011-0954-3, 21424580.
52. Muñoz AJ, Hernández-Chávez G, De Anda R, Martínez A, Bolívar F, Gosset G. Metabolic engineering of Escherichia coli for improving L-3,4-dihydroxyphenylalanine (L-DOPA) synthesis from glucose. J Ind Microbiol Biotechnol 2011, 38:1845-1852. 10.1007/s10295-011-0973-0, 21512819.
53. Lee J-Y, Xun L. Novel biological process for l-dopa production from l-tyrosine by p-hydroxyphenylacetate 3-hydroxylase. Biotechnol Lett 1998, 20:479-482.
54. Noel JP, Louie GV, Bowman ME, Moore BS, Moffitt MC. Substrate switched ammonia lyases and mutases 2009, United States: Patent Application No. 2009/0011400 A1.
55. Fowler ZL, Gikandi WW, Koffas MAG. Increased malonylcoenzyme A biosynthesis by tuning the Escherichia coli metabolic network and its Application to flavanone production. Appl Environ Microbiol 2009, 75:5831-5839. 10.1128/AEM.00270-09, 2747866, 19633125.
56. Lee D, Douglas CJ. Two divergent members of a tobacco 4-coumarate:coenzyme A ligase (4CL) gene family. cDNA structure, gene inheritance and expression, and properties of recombinant proteins. Plant Physiol 1996, 112:193-205. 10.1104/pp.112.1.193, 157938, 8819324.
57. Yun MS, Chen W, Deng F, Kiyokawa T, Mametsuka K, Yogo Y. An in vitro screening assay to discover novel inhibitors of 4-coumarate:CoA ligase. Pest Manag Sci 2006, 62:1065-1071. 10.1002/ps.1277, 16900579.
58. Santos CN, Xiao W, Stephanopoulos G. Rational, combinatorial, and genomic approaches for engineering L-tyrosine production in Escherichia coli. Proc Natl Acad Sci USA 2012, 109:13538-13543. 10.1073/pnas.1206346109, 3427108, 22869698.
59. Bernini R, Crisante F, Ginnasi MC. A convenient and safe O-methylation of flavonoids with dimethyl carbonate (DMC). Molecules 2011, 16:1418-1425. 10.3390/molecules16021418, 21307820.
60. Neidhardt FC, Bloch PL, Smith DF. Culture medium for enterobacteria. J Bacteriol 1974, 119:736-747. 245675, 4604283.
61. Lutz R, Bujard H. Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res 1997, 25:1203-1210. 10.1093/nar/25.6.1203, 146584, 9092630.
62. Lee TS, Krupa RA, Zhang F, Hajimorad M, Holtz WJ, Prasad N, Lee SK, Keasling JD. BglBrick vectors and datasheets: a synthetic biology platform for gene expression. J BiolEng 2011, 5:12.
63. Anderson JC, Dueber JE, Leguia M, Wu GC, Goler JA, Arkin AP, Keasling JD. BglBricks: a flexible standard for biological part assembly. J Biol Eng 2010, 4:1. 10.1186/1754-1611-4-1, 2822740, 20205762.